Home

Omeros Corporation - Common Stock (OMER)

7.3600
-0.6500 (-8.11%)
NASDAQ · Last Trade: Apr 4th, 1:08 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Earnings Scheduled For March 31, 2025benzinga.com
Via Benzinga · March 31, 2025
What's Next: Omeros's Earnings Previewbenzinga.com
Via Benzinga · March 28, 2025
Earnings Scheduled For November 13, 2024benzinga.com
Via Benzinga · November 13, 2024
Earnings Outlook For Omerosbenzinga.com
Via Benzinga · November 12, 2024
OMER Stock Earnings: Omeros Misses EPS for Q2 2024investorplace.com
OMER stock results show that Omeros missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 7, 2024
OMER Stock Earnings: Omeros Misses EPS for Q1 2024investorplace.com
OMER stock results show that Omeros missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 15, 2024
Top Wall Street Forecasters Revamp Omeros Price Expectations Ahead Of Q4 Earningsbenzinga.com
Via Benzinga · March 28, 2025
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 17, 2025
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · March 17, 2025
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga.com
Via Benzinga · December 23, 2024
OMER Stock Earnings: Omeros Misses EPS for Q4 2023investorplace.com
OMER stock results show that Omeros missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · April 1, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 19, 2024
Nasdaq Jumps 100 Points, US Initial Jobless Claims Declinebenzinga.com
Via Benzinga · December 19, 2024
Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surgesbenzinga.com
Omeros announces positive results from a pivotal narsoplimab trial in TA-TMA, showing significant survival benefits and advancing regulatory submissions.
Via Benzinga · December 19, 2024
Gold Falls Sharply, Lamb Weston Shares Plungebenzinga.com
Via Benzinga · December 19, 2024
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursdaybenzinga.com
Via Benzinga · December 19, 2024
Jim Cramer Prefers FedEx Over This Delivery Giant That 'Screwed Up A Lot Of Holiday Seasons'benzinga.com
Via Benzinga · December 3, 2024
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · November 22, 2024
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 18, 2024
Crude Oil Moves Higher; Deere Cuts Profit Outlookbenzinga.com
Via Benzinga · May 16, 2024
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 16, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · May 16, 2024
US Stocks Edge Higher; Initial Jobless Claims Fallbenzinga.com
Via Benzinga · May 16, 2024
Earnings Scheduled For April 1, 2024benzinga.com
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
Via Benzinga · April 1, 2024
Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarterbenzinga.com
The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, but it remained in the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, while the S&P 500 surged to a new all-time high and also recorded its best first-quarter performance in five years.
Via Benzinga · April 1, 2024